The Latest in B Cell Lymphoma

Immunotherapies shape the treatment landscape for hematologic malignancies

August 15, 2018

Caution urged over real-world bleeding risk with ibrutinib

August 14, 2018

Make The Diagnosis - September 2018

August 14, 2018

B Cell Lymphoma

Mogamulizumab prolongs PFS in CTCL

August 14, 2018

B Cell Lymphoma

Groups release guidelines for CAR T treatment in children

August 10, 2018

B Cell Lymphoma

Team recommends melanoma screening in CLL

August 10, 2018

B Cell Lymphoma

Frequent BCCs linked to blood cancers

August 9, 2018

B Cell Lymphoma

Increased B-cell lymphoma risk with JAK1/2 inhibitors

August 8, 2018

B Cell Lymphoma

Company narrows focus of development for tazemetostat

August 5, 2018

B Cell Lymphoma

PET/CT accurately predicts MCL stage

August 2, 2018

Treatment improves PFS in early stage FL

August 2, 2018

Drug receives orphan designation for MM

August 1, 2018

B Cell Lymphoma

CHMP supports expanded approval for epoetin alfa products

July 31, 2018

B Cell Lymphoma

Drug receives fast track designation for WM

July 26, 2018

B Cell Lymphoma

Rituximab reduces risk of follicular lymphoma transformation

July 25, 2018